Comparison of Positive Psychotherapy and Cognitive-Behavioral Psychotherapy for Depression

NCT ID: NCT02572921

Last Updated: 2015-10-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the effects of the Positive Psychotherapy on depressive symptoms and on happiness compared with regular cognitive behavioral therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Positive Psychotherapy (PPT) focuses on increasing well-being and positive emotions rather than ameliorating deficits in contrast to standard psychotherapy.

A lack of positive emotions, engagement and felt meaning are typically viewed as consequences or mere correlates of depression, while the PPT suggests that these may be causal for depression. Therefore building positive emotion, engagement and meaning will alleviate depression.

Thus PPT may offer a new way to treat and prevent depression.

The aim of this study is to compare the effects of the Positive Psychotherapy on depressive symptoms, life satisfaction and happiness in comparison to standard cognitive behavior psychotherapy (regular cognitive behavioral therapy).

60 mildly to moderately depressed patients are randomly assigned to the Positive Psychotherapy group or the regular cognitive behavioral therapy group.

Both treatments (primary intervention group and control group) are conducted in an outpatient group therapy setting with 14 sessions and a duration of 2-hours-per-week in small groups of 6 or 7 patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Positive Psychotherapy

Experimental Group (Positive Psychotherapy)

Group Type EXPERIMENTAL

Positive Psychotherapy

Intervention Type BEHAVIORAL

The Positive Psychotherapy Group Treatment was developed by Martin Seligman and Tayyab Rashid (2013) and consists of 14 weekly group sessions of 2 hours. The strictly manualized program includes the following components:

positive orientation and introduction, character strengths, signature strengths, good vs. bad memories, forgiveness, gratitude, satisficing vs. maximising, meaningful life, posttraumatic growth, hope and optimism, positive communication, signature strengths of others, savouring and slowness, altruism and the last session is about the integration of all these components to the "full life".

Cognitive Behavioral Therapy

Active Control Group (Cognitive Behavioral Therapy)

Group Type ACTIVE_COMPARATOR

Cognitive behavioral therapy

Intervention Type BEHAVIORAL

This well-established, cognitive-behavior group therapy was developed by Schaub, Roth and Goldmann (2006) and consists of 12 weekly group sessions of 2 hours. The strictly manualized program includes the following components: education, building up activities, cognitive restructuring, relapse prevention. Moreover, there are 2 sessions added to the standard program: one session concerning savouring and the other one concerning stress reduction. Thus the whole program consists of 14 sessions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Positive Psychotherapy

The Positive Psychotherapy Group Treatment was developed by Martin Seligman and Tayyab Rashid (2013) and consists of 14 weekly group sessions of 2 hours. The strictly manualized program includes the following components:

positive orientation and introduction, character strengths, signature strengths, good vs. bad memories, forgiveness, gratitude, satisficing vs. maximising, meaningful life, posttraumatic growth, hope and optimism, positive communication, signature strengths of others, savouring and slowness, altruism and the last session is about the integration of all these components to the "full life".

Intervention Type BEHAVIORAL

Cognitive behavioral therapy

This well-established, cognitive-behavior group therapy was developed by Schaub, Roth and Goldmann (2006) and consists of 12 weekly group sessions of 2 hours. The strictly manualized program includes the following components: education, building up activities, cognitive restructuring, relapse prevention. Moreover, there are 2 sessions added to the standard program: one session concerning savouring and the other one concerning stress reduction. Thus the whole program consists of 14 sessions.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of Depression (Major depressive disorder, recurrent: mild to moderate; Major depressive disorder, single episode: mild to moderate; Dysthymic disorder)
* Patients should be between age 18 and 60

Exclusion Criteria

* Any current treatment for depression
* Substance related or alcohol related disorder (within the last 12 months)
* Panic disorder
* Manic or hypomanic disorder
* Psychotic disorder \* refusal to participate in a 14 weeks psychotherapy treatment
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Wagner-Jauregg Provincial Neuropsychiatric Clinic

INDIV

Sponsor Role collaborator

University of Salzburg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mag. Linda Maria Furchtlehner

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anton-Rupert Laireiter, Univ.-Prof.Dr.

Role: STUDY_CHAIR

Paris Lodron University of Salzburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beratungsstelle für Klinische Psychologie, Psychotherapie und Gesundheitspsychologie

Salzburg, Salzburg, Austria

Site Status

Wagner-Jauregg- Hospital

Linz, Upper Austria, Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

USalzburg

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Group Psychotherapy in Long COVID
NCT06726772 COMPLETED NA